BLR-17620-33950
2 vaccinations
4 coded responses
15 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 920 / CA
- Registered
- 2021-05-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-21
Dose 1 — Pfizer-BioNTech
-
2021-05-22
Registered in v-safe
-
2021-05-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
- 2021-05-28
- 2021-06-04
-
2021-06-21
Dose 2 — Pfizer-BioNTech
-
2021-06-25
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Site: PainFree text:MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-26
- 2021-06-28
- 2021-07-07
- 2021-07-13
-
2021-07-19
Survey response — day 28, dose 2MedDRA: Acne, Heavy menstrual bleeding, Menopause — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Ive been in a premenopausal stage for 6 mos, 2-3 periods during that time which were lighter & shorter than my normal. 2 weeks after the 2nd vaccine, I experienced a very heavy period lasting much longer than my normal. Also, minor acne on my faceMedDRA releases: 2024-11 · check-in free text available
-
2021-09-21
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Good · Be unable to do your normal daily activitiesFree text: Heavier and longer than normal menstrual periods (3 of them, every 4 weeks, since 2nd vaccination).Before vaccination, I was perimenopausal. No underlying medical issues that have caused the change in my menstrual cycleMedDRA releases: 2024-11 · check-in free text available
-
2022-06-21
Survey response — 12 months, dose 2MedDRA: Body temperature increased, Fatigue, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Experienced extreme fatigue and low grade temperature. Took at-home Covid-19 test with a positive resultMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-21 | Pfizer-BioNTech | |
| 2 | 2021-06-21 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Release 9 — day 28, dose 2
Symptoms: Ive been in a premenopausal stage for 6 mos, 2-3 periods during that time which were lighter & shorter than my normal. 2 weeks after the 2nd vaccine, I experienced a very heavy period lasting much longer than my normal. Also, minor acne on my face
Release 9 — 3 months, dose 2
Symptoms: Heavier and longer than normal menstrual periods (3 of them, every 4 weeks, since 2nd vaccination).Before vaccination, I was perimenopausal. No underlying medical issues that have caused the change in my menstrual cycle
Release 12 — 12 months, dose 2
Symptoms: Experienced extreme fatigue and low grade temperature. Took at-home Covid-19 test with a positive result
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Acne | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Menopause | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release